Tag: Biotech funding for heart disease

**New Biotech Firm Raises $300 Million with Focus on Heart Disease**In a bold move that has sent shockwaves through the biotech industry, MyoKardia's former CEO, Tassos Gianakakos, has announced the launch of a new...